Hydroxychloroquine sulfate
- CAS No.
- 747-36-4
- Chemical Name:
- Hydroxychloroquine sulfate
- Synonyms
- HYDROXYCHLOROQUINE SULPHATE;Hydroxycloroquine sulfate;7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline sulfate;Quensyl;Ercoquin;Plaquinol;HCQ sulfate;plaquenilsulfate;Hydroxychloroquin;Acidum iopanoicum
- CBNumber:
- CB4423632
- Molecular Formula:
- C18H28ClN3O5S
- Molecular Weight:
- 433.95
- MOL File:
- 747-36-4.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/5/21 21:51:03
| Melting point | 240 °C |
|---|---|
| storage temp. | protect from light |
| solubility | H2O: >20mg/mL |
| form | Crystalline Powder |
| color | white to off-white |
| Water Solubility | FREELY SOLUBLE |
| Merck | 14,4818 |
| Stability | Stable for 2 years from date of purchase as supplied. Solutions in water may be stored at -20°C for up to 3 months. |
| InChIKey | JCBIVZZPXRZKTI-UHFFFAOYSA-N |
| EPA Substance Registry System | Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-, sulfate (1:1) (747-36-4) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319 | |||||||||
| Precautionary statements | P301+P312+P330-P305+P351+P338 | |||||||||
| Hazard Codes | Xn,Xi | |||||||||
| Risk Statements | 42/43-36/37/38-36-22 | |||||||||
| Safety Statements | 37/39-26 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | KK3342500 | |||||||||
| HS Code | 29334990 | |||||||||
| NFPA 704 |
|
Hydroxychloroquine sulfate price More Price(9)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | PHR1782 | Hydroxychloroquine Sulfate Pharmaceutical Secondary Standard; Certified Reference Material | 747-36-4 | 1G | ₹24312.95 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | H-157 | Hydroxychloroquine sulfate solution 1?mg/mL (Methanol:Water (80:20) (v/v), (as free base)), certified reference material, ampule of 1?mL, Cerilliant? | 747-36-4 | 1ML | ₹14802.9 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | H0915 | Hydroxychloroquine sulfate ≥98% (HPLC), powder | 747-36-4 | 5MG | ₹11961.63 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | H0915 | Hydroxychloroquine sulfate ≥98% (HPLC), powder | 747-36-4 | 25MG | ₹47857.33 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | 90527 | Hydroxychloroquine sulfate analytical standard | 747-36-4 | 50MG | ₹5174.35 | 2022-06-14 | Buy |
Hydroxychloroquine sulfate Chemical Properties,Uses,Production
Description
Hydroxychloroquine sulfate (also known as hydroxychloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria, lupus erythematosus, and rheumatoid arthritis. It is sold under the brand name Plaquenil and it is also sold as a generic medicine. It is available in tablets of 155mg base (200mg salt).
Hydroxychloroquine sulfate has not been approved for the treatment of COVID-19. It has been used experimentally to treat certain people with COVID-19, including hospitalized patients. Hydroxychloroquine sulfate is being used to try and stop the COVID-19 virus from spreading inside your body. This may help you to get better.
Hydroxychloroquine sulfate is experimental because we do not know if it works for COVID-19. It is not approved by FDA for the treatment of COVID-19, but emergency use has been authorized for adults and adolescents who weigh 50 kg (110 pounds) or more and are hospitalized with COVID-19 if a clinical trial is not available or you are not able to participate in a clinical trial. There is limited information known about the safety and effectiveness (whether this will make you better) of using hydroxychloroquine sulfate for hospitalized patients with COVID-19.
Chemical Properties
White Cyrstalline Solid
Uses
Hydroxychloroquine Sulfate can be used as a pharmaceutical secondary standard for the determination of the analyte in pharmaceutical formulations, and biological samples by various analytical techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
General Description
Hydroxychloroquine Sulfate (Hydroxychloroquine Sulphate) is a salt of hydroxychloroquine (HCQ, Plaquenil), a 4-aminoquinoline based antiviral drug.
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Pharmacology
Antimalarial action: Hydroxychloroquine binds to DNA, interfering with protein synthesis. It also inhibits DNA and RNA polymerases. It’s active against asexual erythrocytic forms of Plasmodium malariae, P. ovale, P. vivax, and many strains of P. falciparum.
Amebicidal action: Mechanism of action is unknown.
Anti-inflammatory action: Mechanism of action is unknown. Drug may antagonize histamine and serotonin and inhibit prostaglandin effects by inhibiting conversion of arachidonic acid to prostaglandin F2; it may also inhibit chemotaxis of polymorphonuclear leukocytes, macrophages, and eosinophils.
Pharmacokinetics
Absorption: Absorbed readily and almost completely.
Distribution: Bound to plasma proteins. It’s concentrated in the liver, spleen, kidneys, heart, and brain and is strongly bound in melanin-containing cells.
Metabolism: Metabolized by the liver to desethylchloroquine and desethyl hydroxychloroquine.
Excretion: Most of an administered dose is excreted unchanged in urine. Drug and its metabolites are excreted slowly in urine; unabsorbed drug is excreted in feces. Small amounts of drug may be present in urine for months after it’s discontinued. Drug appears in breast milk.
Clinical Use
Hydroxychloroquine sulfate is highly water soluble and exists in two different forms of different melting points. It is readily absorbed on oral administration, reaching peak plasma levels within 1 to 3 hours. It concentrates in organs such as the liver, spleen, kidneys, heart, lung, and brain, thereby prolonging elimination. Hydroxychloroquine is metabolized by N-dealkylation of the tertiary amines, followed by oxidative deamination of the resulting primary amine to the carboxylic acid derivative. In addition to possessing corneal and renal toxicity, hydroxychloroquine also may cause CNS, neuromuscular, GI, and hematological side effects. Hydroxychloroquine sulfate is indicated for the treatment of rheumatoid arthritis, lupus erythematosus, and malaria.
Side effects
In addition to possessing corneal and renal toxicity, hydroxychloroquine also may cause CNS, neuromuscular, GI, and hematological side effects. Hydroxychloroquine sulfate is indicated for the treatment of rheumatoid arthritis, lupus erythematosus, and malaria
Overdosage
Symptoms of drug overdose may appear within 30 minutes after ingestion and may include headache, drowsiness, visual changes, CV collapse, and seizures followed by respiratory and cardiac arrest.
Treatment is symptomatic. Empty stomach by emesis or lavage. After lavage, activated charcoal in an amount at least five times the estimated amount of drug ingested may be helpful if given within 30 minutes of ingestion.
Ultra-short-acting barbiturates may help control seizures. Intubation may become necessary. Peritoneal dialysis and exchange transfusions may also be useful. Forced fluids and acidification of the urine are helpful after the acute phase.
Drug interactions
Anti-arrhythmics: increased risk of ventricular arrhythmias when hydroxychloroquine administered with amiodarone – avoid concomitant use
Digoxin: Hydroxychloroquine sulfate has been reported to increase plasma digoxin levels: serum digoxin levels should be closely monitored in patients receiving concomitant therapy.
Antibacterials: increased risk of ventricular arrhythmias when hydroxychloroquine administered with moxifloxacin – avoid concomitant use.
Ciclosporin: hydroxychloroquine increases plasma concentration of ciclosporin (increased risk of toxicity) .
Antacids: as with chloroquine, antacids may reduce absorption of hydroxychloroquine so it is advised that a 4 hour interval be observed between hydroxychloroquine and antacid dosaging.
Antidiabetic medicines: As hydroxychloroquine may enhance the effects of hypoglycaemic treatment, a decrease in doses of insulin or antidiabetic drugs may be required.
Tamoxifen: may enhance the adverse/toxic effect of Hydroxychloroquine. Specifically, concomitant use of tamoxifen and hydroxychloroquine may increase the risk of retinal toxicity.
Hydroxychloroquine sulfate Preparation Products And Raw materials
Raw materials
1of2
chevron_rightPreparation Products
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| GLR Innovations | +91 9891111994 | New Delhi, India | 4542 | 58 | Inquiry |
| TAGOOR LABORATORIES PVT LTD | +919700187008 | AndhraPradesh, India | 93 | 58 | Inquiry |
| Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
| Micro Orgo Chem | +91-91-022-24969510 +91-9082984052 | Mumbai, India | 66 | 58 | Inquiry |
| Zuhhad international | +91-8454840801 +91-8454840801 | Mumbai, India | 21 | 58 | Inquiry |
| Gonane Pharma | +91-9819380043 +91-9819380043 | NaviMumbai, India | 192 | 58 | Inquiry |
| KARPSCHEM LABORATORIES | +91-7249203006 +91-7249203006 | Maharashtra, India | 786 | 58 | Inquiry |
| Bajaj Healthcare Ltd | +91-2266177400 +91-2266177400 | Maharashtra, India | 86 | 58 | Inquiry |
| Ipca Laboratories Ltd | +91-2262105000 +91-2262105000 | Maharashtra, India | 61 | 58 | Inquiry |
| Mangalam Drugs and Organics Ltd | +91-2222616300 +91-2222616200 | Maharashtra, India | 37 | 58 | Inquiry |
| Supplier | Advantage |
|---|---|
| GLR Innovations | 58 |
| TAGOOR LABORATORIES PVT LTD | 58 |
| Jigs Chemical ltd | 58 |
| Micro Orgo Chem | 58 |
| Zuhhad international | 58 |
| Gonane Pharma | 58 |
| KARPSCHEM LABORATORIES | 58 |
| Bajaj Healthcare Ltd | 58 |
| Ipca Laboratories Ltd | 58 |
| Mangalam Drugs and Organics Ltd | 58 |
Related articles
- The mechanism of action and precautions of Hydroxychloroquine sulfate
- Hydroxychloroquinone sulfate is a derivative of chloroquine and is the cornerstone of treating autoimmune diseases.
- Mar 22，2024
- Hydroxychloroquine sulfate: mechanism of action and clinical applications
- Hydroxychloroquine sulfate is a versatile medication with immune-modulating, anti-inflammatory properties used for malaria and....
- Sep 21，2023
- What is Hydroxychloroquine sulfate?
- Hydroxychloroquine sulfate (also known as hydroxychloroquine) is an antimalarial medicine approved in the United States for ei....
- Jul 22，2020
747-36-4(Hydroxychloroquine sulfate)Related Search:
1of4
chevron_right